In-Vitro Diagnostic Market | Growth, Trends, and Forecast (2019-2024)

In-Vitro Diagnostic Market - Growth, Trends, and Forecast (2019 - 2024)

The market is segmented by Technique, Product (Instrument, Reagent, Data management System), Usability, Application, End User and Geography

PURCHASE REPORT

In-Vitro Diagnostic-1

Study Period:

2016-2024

Base Year:

2018

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

Key Players:

PURCHASE REPORT

Market Overview

Global In-Vitro Diagnostic market was valued at USD 59,272.87 million in 2018 and is estimated to be valued at USD 82,626.27 million in 2024, witnessing a CAGR of 4.81%. The growth of the global IVD market can be attributed to the high prevalence of chronic and infectious diseases. Chronic diseases are a growing global challenge, and according to WHO estimates, account for approximately 60% of all deaths, worldwide. The current market is also growing due to the use of advanced technologies in the IVD market. There has been a paradigm shift from traditional diagnostics to a new generation diagnostics of that works at the gene level. This was made possible by the inclusion of advanced technologies, such as genetic testing, molecular diagnostics, polymerase chain reaction (PCR) and next-generation sequencing (NGS).

Scope of the Report

As per the scope of this report, in vitro diagnostics involves medical devices and consumables that are utilized to perform in vitro tests on various biological samples. They are used for the diagnosis of various medical conditions, such as chronic diseases.

By Technique
Histochemistry
Molecular Diagnostics
Hematology
POC Testing
Self-blood Glucose Testing
Immunochemistry
Other Techniques
By Product
Instrument
Reagent
Data Management System
By Usability
Disposable IVD Devices
Reusable IVD Devices
By Application
Infectious Disease
Diabetes
Cancer/Oncology
Cardiology
Autoimmune Disease
Nephrology
Drug Testing
Other Applications
By End Users
Academia
Laboratories
Hospitals & Clinics
Other End Users
Geography
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
  • MARKET SEGMENTATION
    • By Technique
      • Histochemistry
      • Molecular Diagnostics
      • Hematology
      • POC Testing
      • Self-blood Glucose Testing
      • Immunochemistry
      • Other Techniques
    • By Product
      • Instrument
      • Reagent
      • Data Management System
    • By Usability
      • Disposable IVD Devices
      • Reusable IVD Devices
    • By Application
      • Infectious Disease
      • Diabetes
      • Cancer/Oncology
      • Cardiology
      • Autoimmune Disease
      • Nephrology
      • Drug Testing
      • Other Applications
    • By End Users
      • Academia
      • Laboratories
      • Hospitals & Clinics
      • Other End Users
    • Geography
      • North America
        • US
        • Canada
        • Mexico
      • Europe
        • Germany
        • UK
        • France
        • Italy
        • Spain
        • Rest of Europe
      • Asia Pacific
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • Rest of Asia-Pacific
      • Middle East and Africa
        • GCC
        • South Africa
        • Rest of Middle East and Africa
      • South America
        • Brazil
        • Argentina
        • Rest of South America

Key Market Trends

Reagent is Expected to hold its Highest Market Share in the Product Segment

In the product segment of the In-Vitro Diagnostic market, the reagent is believed to have the largest market size and is expected to witness a CAGR of 4.8% in the forecast period.

The reagent segment of the market studied includes chemical, biological, or immunological components, solutions, or preparations intended by the manufacturer to be used during the in-vitro diagnosis process. Given the high cost of many diagnostic platforms, it is common for manufacturers to lease equipment instead of selling technology outright to end users. In these arrangements, the lease is tied to contracts to purchase associated reagents or assays for the equipment over the life of the contract. Many diagnostic companies have in excess of 75% of sales from consumables such as assays and reagents, and such agreements guarantee the generation of cyclic revenues associated with the sale of reagents and other consumables.

Many developing countries have established local immunoassay reagent programs to manufacture low-cost, high-quality immunoassay reagents. Kits from these projects are now beginning to become available and are likely to fuel the market expansion.

In-Vitro Diagnostic-2

North America Dominates the Market and is Expected to continue its Dominance in the Forecast Period

North America currently dominates the market for In-Vitro Diagnostic and is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future owing to the well-established healthcare industry and rising prevalence of the chronic diseases in the region. The United States holds the majority of the market in the North America region; this is due to the rising healthcare expenditure, along with rapid adoption of point-of-care testing.

In-Vitro Diagnostic-3

Competitive Landscape

The In-Vitro Diagnostic market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancement and product innovation, mid-size to smaller companies are increasing their market presence by introducing new products at lesser prices. Companies like Thermo Fischer Scientific Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., Siemens Healthcare GmbH and F. Hoffmann-La Roche AG. holds the substantial market share in the In-Vitro Diagnostic market.

Major Players

  1. Thermo Fischer Scientific Inc.
  2. Qiagen N.V.
  3. Bio-Rad Laboratories, Inc.
  4. Siemens Healthcare GmbH
  5. F. Hoffmann-La Roche AG

* Complete list of players covered available in the table of contents below

Image5

Customize the Report

80% of our clients ask for some sort of customisation, be it specific countries / companies / segments.

What are you looking for?

Please Enter a Valid Email ID!

Please Enter a Valid Message!

Table of Contents

  1. INTRODUCTION
    1. Study Deliverables
    2. Study Assumptions
    3. Scope of the Study
  2. RESEARCH METHODOLOGY
  3. EXECUTIVE SUMMARY
  4. MARKET DYNAMICS
    1. Market Overview
    2. Market Drivers
      1. High Prevalence of Chronic Diseases
      2. Increasing Use of Point-of-care (POC) Diagnostics
      3. Advanced Technologies
      4. Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
    3. Market Restraints
      1. Stringent Regulations
      2. Cumbersome Reimbursement Procedures
    4. Porter's Five Force Analysis
      1. Threat of New Entrants
      2. Bargaining Power of Buyers/Consumers
      3. Bargaining Power of Suppliers
      4. Threat of Substitute Products
      5. Intensity of Competitive Rivalry
  5. MARKET SEGMENTATION
    1. By Technique
      1. Histochemistry
      2. Molecular Diagnostics
      3. Hematology
      4. POC Testing
      5. Self-blood Glucose Testing
      6. Immunochemistry
      7. Other Techniques
    2. By Product
      1. Instrument
      2. Reagent
      3. Data Management System
    3. By Usability
      1. Disposable IVD Devices
      2. Reusable IVD Devices
    4. By Application
      1. Infectious Disease
      2. Diabetes
      3. Cancer/Oncology
      4. Cardiology
      5. Autoimmune Disease
      6. Nephrology
      7. Drug Testing
      8. Other Applications
    5. By End Users
      1. Academia
      2. Laboratories
      3. Hospitals & Clinics
      4. Other End Users
    6. Geography
      1. North America
        1. US
        2. Canada
        3. Mexico
      2. Europe
        1. Germany
        2. UK
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
      3. Asia Pacific
        1. China
        2. Japan
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia-Pacific
      4. Middle East and Africa
        1. GCC
        2. South Africa
        3. Rest of Middle East and Africa
      5. South America
        1. Brazil
        2. Argentina
        3. Rest of South America
  6. COMPETITIVE LANDSCAPE
    1. Company Profiles
      1. BioMérieux
      2. Danaher Corporation
      3. F. Hoffmann-La Roche AG
      4. Becton, Dickinson and Company
      5. Bio-Rad Laboratories, Inc.
      6. Abbott Laboratories
      7. Arkray Inc.
      8. Sysmex Corporation
      9. Ortho Clinical Diagnostics
      10. Siemens Healthcare GmbH
      11. Thermo Fischer Scientific Inc.
      12. QIAGEN N.V.
    2. *List Not Exhaustive
  7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments